Immunic Inc (IMUX)
Healthcare
Biotechnology
14.10 $
+0.9%
vs. previous close
Closing price · As of: 3. Aug 2026
Immunic Inc (IMUX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -17 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -20 | -17 | -14 | -24 | -17 | -21 | -23 | -22 | -25 | -20 | -19 | -17 | -81 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | |
| 1.8 | 1.7 | 1.6 | 2.8 | 1.9 | 1.9 | 2.0 | 2.0 | 1.9 | 3.6 | 1.3 | 4.5 | 11 | |
| 1.9 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 2.1 | 3.7 | 6.1 | -4.0 | 2.9 | 1.6 | 0.1 | 1.6 | 0.2 | 1.7 | -1.7 | 11 | 11 | |
| 0.0 | 0.0 | 0.2 | 0.0 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.1 | |
| 4.3 | 0.0 | -0.2 | 0.0 | -0.2 | -0.1 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | -0.1 | |
| 0.1 | – | 0.1 | – | – | – | 0.1 | – | 0.1 | – | 0.1 | – | – | |
| 0.1 | 0.3 | 0.6 | 74 | 0.0 | 0.0 | 0.1 | 0.0 | 66 | 0.0 | 0.1 | 189 | 254 | |
| -15 | -18 | -13 | 51 | -18 | -21 | -23 | -21 | 41 | -20 | -20 | 171 | 172 | |
| -20 | -17 | -14 | -24 | -17 | -21 | -23 | -22 | -25 | -20 | -19 | -17 | -81 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.